Education
About Us
Working with TipRanks
Follow Us
Milestone Scientific (MLSS)
:MLSS
MLSS Stock Chart & Stats
$0.39
$0.17(16.41%)
At close: 4:00 PM EST
$0.39
$0.17(16.41%)
Day’s Range― - ―
52-Week Range$0.35 - $1.39
Previous CloseN/A
Volume1.27M
Average Volume (3M)172.66K
Market Cap
$29.73M
Enterprise Value$52.04M
Total Cash (Recent Filing)$1.27M
Total Debt (Recent Filing)$1.09M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Nov 12, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding78,559,150
10 Day Avg. Volume233,274
30 Day Avg. Volume172,658
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue5.73
Enterprise Value/Gross Profit7.87
Enterprise Value/Ebitda-7.59
Forecast
1Y Price Target
$1.63Price Target Upside317.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Management TeamMilestone strengthened its management team with the appointment of a new CEO and a Senior Vice President, Global Head of Sales and Marketing.
Market PenetrationMilestone plans to leverage the relationships of its new management team to increase penetration in the existing markets.
Medicare MarketThe company has won coverage from three of the 12 Medicare Administrative Contractors for its CompuFlo System, which can drive growth in the Medicare market segment of approximately 3.6 million procedures per annum.
Bears Say
Financial Performance2Q25 revenue was below expectations, leading to a reduction in the 12-month price target from $3.00 to $2.00.
Revenue And Margin Estimates2Q25 results led to lowered 2025 and 2026 revenue and gross margin estimates, and widened GAAP loss per share estimates.
Milestone Scientific News
MLSS FAQ
What was Milestone Scientific’s price range in the past 12 months?
Milestone Scientific lowest stock price was $0.35 and its highest was $1.39 in the past 12 months.
What is Milestone Scientific’s market cap?
Milestone Scientific’s market cap is $29.73M.
When is Milestone Scientific’s upcoming earnings report date?
Milestone Scientific’s upcoming earnings report date is Nov 12, 2025 which is in 5 days.
How were Milestone Scientific’s earnings last quarter?
Milestone Scientific released its earnings results on Aug 14, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.01.
Is Milestone Scientific overvalued?
According to Wall Street analysts Milestone Scientific’s price is currently Undervalued.
Does Milestone Scientific pay dividends?
Milestone Scientific does not currently pay dividends.
What is Milestone Scientific’s EPS estimate?
Milestone Scientific’s EPS estimate is -0.02.
How many shares outstanding does Milestone Scientific have?
Milestone Scientific has 78,559,150 shares outstanding.
What happened to Milestone Scientific’s price movement after its last earnings report?
Milestone Scientific reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went up 12.263%.
Which hedge fund is a major shareholder of Milestone Scientific?
Currently, no hedge funds are holding shares in MLSS
Milestone Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.63 (317.95% Upside)
$1.63 (317.95% Upside)
Insider Transactions
Sold Shares
Worth $171.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.94%
12-Months-Change
Fundamentals
Return on Equity
-123.50%
Trailing 12-Months
Asset Growth
-32.94%
Trailing 12-Months
Company Description
Milestone Scientific
Milestone Scientific Inc. (MLSS) is a biotechnology company specializing in the development of innovative drug delivery technology and solutions. The company operates primarily in the medical device sector, focusing on the dental and obstetric markets. Milestone's core products include the CompuFlo® instrument, which utilizes patented technology for precise and controlled delivery of anesthetic agents, enhancing patient comfort and safety during procedures.
MLSS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth in the third quarter, strong gross margins, and strategic progress in the medical division with Medicare Part B alignment. However, concerns remain with the lack of revenue from China and an overall revenue decline over the nine-month period. Despite these challenges, the company seems well-positioned for future growth, particularly in international markets.View all MLSS earnings summariesMLSS Stock 12 Month Forecast
Average Price Target
$1.63
▲(317.95% Upside)
Technical Analysis
Retractable Technologies
―
Precision Optics Corporation
―
Nephros
―
Femasys
―
NexGel Inc
―
Ownership Overview
18.25% Insiders
3.82% Mutual Funds
0.19% Other Institutional Investors
75.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---